Increased anterior default-mode network homogeneity in first-episode, drug-naive major depressive disorder: A

Wenbin Guo1, Xilong Cui1, Feng Liu2

  • 1Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; Mental Health Institute of the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; National Clinical Research Center on Mental Disorders, Changsha, Hunan 410011, China; National Technology Institute on Mental Disorders, Changsha, Hunan 410011, China; Hunan Key Laboratory of Psychiatry and Mental Health, Changsha, Hunan 410011, China.

Abstract

Insights

Major depressive disorder (MDD) is linked to increased default-mode network (DMN) homogeneity in the left superior medial prefrontal cortex. This finding in drug-naive patients highlights the DMN's role in MDD neurophysiology.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Imaging

Background:

  • Default-mode network (DMN) homogeneity alterations are implicated in major depressive disorder (MDD) but findings are inconsistent.
  • Clinical and methodological variability may explain inconsistent findings and limited reproducibility.
  • This study investigates DMN homogeneity in first-episode, drug-naive MDD patients.

Purpose of the Study:

  • To examine alterations in DMN homogeneity in two independent samples of first-episode, drug-naive MDD patients.
  • To identify brain regions with abnormal DMN homogeneity common to MDD patients.
  • To explore the neurophysiological underpinnings of MDD.

Main Methods:

  • Two independent samples of MDD patients and comparison subjects were analyzed.
  • Network homogeneity (NH) was computed using an overlapping technique.
  • Abnormal NH regions common to both MDD samples were identified.

Main Results:

  • MDD patients showed increased NH in the left superior medial prefrontal cortex (MPFC) compared to controls.
  • This increased NH was observed in an overlapped brain region common to both samples.
  • No significant correlations were found between abnormal NH and HAMD scores.

Conclusions:

  • This is the first study to examine DMN homogeneity in first-episode, drug-naive MDD using two independent samples and an overlapping technique.
  • Increased NH in an anterior DMN region was observed in MDD patients.
  • The findings underscore the DMN's significance in MDD neurophysiology.

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
768
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
873
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.0K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.7K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.8K
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.4K